- £977.45m
- £902.77m
- $1.09bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 785 | 647 | 791 | 901 | 1,093 |
Cost of Revenue | |||||
Gross Profit | 645 | 555 | 664 | 749 | 916 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 609 | 810 | 587 | 986 | 1,097 |
Operating Profit | 176 | -163 | 204 | -85 | -4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 180 | -173 | 190 | -95 | 1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 134 | -148 | 205 | -75 | -3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 134 | -148 | 205 | -53 | 2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 134 | -148 | 205 | -53 | 2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.01 | 0.955 | 1.6 | 2.22 | 2.36 |